An E3 ligase that regulates expression of ESR1 and a co-factor of ESR1 in breast cancer cells.

Read full text
Authors: Shahan Mamoor
Cited by: 0

Abstract

We discovered regulation of ESR1 and GREB1 in breast cancer cells by the E3 ligase RNF168. RNF168 has functions related to DNA damage signaling interacting with H2AX and ubiquitination of the DNA. and is a K27 ubiquitin chain-specific ligase. We demonstrate here that RNF168 expression is a correlate or strong predictor of tumor size in humans with cancer. RNF168 expression was a significant component of the gene signature of the Xist-expressing human embryonic stem cell in humans whose genomes contained an XX (females). Together we describe a relationship between the E3 ligase RNF168 and estrogen steroid hormone signaling which is likely shaped by interactions with Xist at least in part in relation to a recently described requirement for the Xist ncRNA in DNA damage marked by H2AX, a feature which positively associated with tumor size in humans.

Fields of Study & Subjects

Estrogen and related hormone effects Ubiquitin and proteasome pathways Epigenetics and DNA Methylation

Publication details

Journal / source
Zenodo (CERN European Organization for Nuclear Research)
Publication date
12 January 2026